Curt Mazur
Ionis Pharmaceuticals (United States)
ORCID: 0000-0003-3485-9086Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 5 papers. Top paper: “Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis”.
Lisa M. Stanek, Edward V. Wancewicz, Curt Mazur, Melissa M. McAlonis, Kimberly A. Pytel +8 more
Hien Zhao, Andrew G. Reidenbach, Juliana E Gentile, Eric Kuhn, Jill O’Moore +15 more
Hien Zhao, Andrew G. Reidenbach, Juliana E Gentile, Eric Kuhn, Jill O’Moore +15 more
Martin Lackinger, Anastasia Diamantopoulou, Sneha Rao, Yijing Chen, Khakima Khalizova +8 more
Martin Lackinger, Anastasia Diamantopoulou, Sneha Rao, Yijing Chen, Khakima Khalizova +8 more